Validea Detailed Fundamental Analysis

ELEVANCE HEALTH INC (ELV), a large-cap growth stock in the Insurance (Accident & Health) industry, received an 81% rating from Validea's Multi-Factor Investor model, which is based on Pim van Vliet's strategy emphasizing low volatility, strong momentum, and high net payout yields. This score indicates the strategy has "some interest" in ELV, reflecting its underlying fundamentals and valuation, despite neutral performance on specific momentum and net payout yield criteria.

Analysis

Elevance Health Inc. (ELV) has been flagged by Validea's quantitative model based on Pim van Vliet's conservative factor strategy, achieving a score of 81%. This rating indicates a moderate level of interest, as it surpasses the 80% threshold but remains below the 90% level required for a strong conviction signal. The analysis reveals a mixed performance against the strategy's core tenets. ELV passes on market capitalization and, notably, on standard deviation, aligning with the strategy's primary focus on low-volatility stocks. However, the stock demonstrates neutral characteristics for both 'TWELVE MINUS ONE MOMENTUM' and 'NET PAYOUT YIELD', suggesting it currently lacks strong price momentum and a high rate of capital return to shareholders. Critically, despite the favorable 81% composite score, the stock receives a 'FAIL' on the model's 'FINAL RANK', indicating that while it possesses some desirable conservative traits, it does not holistically meet the stringent criteria to be a top-ranked security within this specific multi-factor framework.

Key Decisions for Investors

• Investors employing low-volatility or conservative factor strategies should note that ELV aligns with the core low-risk principle of the van Vliet model but requires further diligence due to its weaknesses in other factors.
• Caution is warranted given the stock's neutral ratings on momentum and net payout yield, and particularly its 'FAIL' on the model's final rank, which suggests it is not a high-conviction candidate under this specific quantitative screen.
• This factor-based analysis should be treated as a screening tool; a fundamental deep-dive into the drivers of ELV's growth, profitability, and capital allocation is necessary before committing capital.